|Articles|August 13, 2015

GSK: Legionnaires Disease Bacteria Causes Temporary Closedown of US Site

August 13, 2015.

The Financial Times reports that GSK has temporarily shut down its Zebulon manufacturing site in North Carolina after a bacteria that causes Legionnaires disease was found in its cooling tower on Tuesday.

GSK said the bacteria had been isolated after routine testing and that it is “working to rectify and restore operations as soon as possible”.

Source: Financial Times

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

GSK: Legionnaires Disease Bacteria Causes Temporary Closedown of US Site

Newsletter

Related Content

From Ambition to Advantage: How Life Sciences Leaders Are Scaling AI

Aidoc Submits Breakthrough-Designated Multi-Triage Device for FDA Approval

How Technology is Moving the Industry Away from Animal Testing: Q&A with Dr. Jo Varshney

Agentic AI Will Transform the Business of Life Sciences

Pharma’s Next Commercial Frontier: Orchestrating Data, AI, and CRM for True Customer Centricity

Trending on PharmExec

Brent Saunders: Eyeing New Horizons

TrumpRX Has a Blind Spot and It Can Redefine Patient Access

FDA Grants National Priority Voucher to Tecvayli Combination in Relapsed or Refractory Multiple Myeloma

Sobi Reaches $1.5 Billion Definitive Agreement with Arthrosi Therapeutics to Acquire Gout Treatment

FDA Approves Enhertu Plus Perjeta as First-Line Therapy for HER2-Positive Metastatic Breast Cancer